Handelsbanken Fonder AB lifted its stake in shares of Genpact Limited (NYSE:G - Free Report) by 12.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 43,000 shares of the business services provider's stock after acquiring an additional 4,900 shares during the quarter. Handelsbanken Fonder AB's holdings in Genpact were worth $1,847,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of G. JPMorgan Chase & Co. raised its stake in Genpact by 192.8% in the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after buying an additional 2,060,595 shares in the last quarter. Los Angeles Capital Management LLC bought a new position in Genpact in the third quarter worth approximately $19,779,000. Tandem Investment Advisors Inc. bought a new position in Genpact in the third quarter worth approximately $17,025,000. Geode Capital Management LLC raised its stake in Genpact by 12.6% in the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock worth $148,142,000 after buying an additional 413,646 shares in the last quarter. Finally, Empowered Funds LLC raised its stake in Genpact by 1,942.3% in the fourth quarter. Empowered Funds LLC now owns 325,379 shares of the business services provider's stock worth $13,975,000 after buying an additional 309,447 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Genpact
In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares of the company's stock, valued at approximately $11,926,218.40. This trade represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by corporate insiders.
Genpact Stock Performance
Shares of G traded up $0.52 during trading hours on Friday, reaching $53.22. 2,318,410 shares of the company traded hands, compared to its average volume of 1,559,439. The stock has a market capitalization of $9.39 billion, a P/E ratio of 18.74, a P/E/G ratio of 1.84 and a beta of 1.20. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The business has a fifty day moving average price of $48.00 and a 200-day moving average price of $43.38.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Equities analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.28%. This is a positive change from Genpact's previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact's dividend payout ratio is presently 23.94%.
Analysts Set New Price Targets
A number of brokerages recently commented on G. Robert W. Baird boosted their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research note on Friday, November 8th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their price target for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Needham & Company LLC lifted their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Finally, Mizuho lifted their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $48.44.
View Our Latest Analysis on G
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report